UPPSALA
Sweden
50
2025-02-06
39
2025-11-18
These are the the leading inventors for applications assigned to OREXO AB:
OREXO AB based in UPPSALA, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PHARMACEUTICAL COMPOSITION COMPRISING ADRENALINE
#2 | 2024-11-12 ✅ Patent 12,138,259 granted on 2024-11-12Method of controlling depression in subjects treated for opioid dependence
#3 | 2024-08-01 ✅ Patent 12,268,684 granted on 2025-04-08Pharmaceutical composition for nasal delivery
#4 | 2024-05-21 ✅ Patent 11,986,472 granted on 2024-05-21Method of controlling alcohol consumption in subjects treated for opioid dependence
#5 | 2024-01-25 ✅ Patent 12,357,573 granted on 2025-07-15NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERY
#6 | 2023-11-09 ✅ Patent 11,957,647 granted on 2024-04-16Pharmaceutical composition comprising adrenaline
#7 | 2023-10-05 ✅ Patent 12,303,472 granted on 2025-05-20Pharmaceutical device for use in intranasal administration
#8 | 2023-04-04 ✅ Patent 11,617,746 granted on 2023-04-04Method of controlling depression in subjects treated for opioid dependence
#9 | 2022-03-24 ✅ Patent 11,737,980 granted on 2023-08-29Pharmaceutical composition for drug delivery
#10 | 2021-12-30 ✅ Patent 11,883,392 granted on 2024-01-30Pharmaceutical composition for nasal delivery
#11 | 2021-02-04 ✅ Patent 11,020,388 granted on 2021-06-01Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#12 | 2021-01-14 ✅ Patent 11,020,387 granted on 2021-06-01Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#13 | 2021-01-14 ✅ Patent 11,433,066 granted on 2022-09-06Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#14 | 2021-01-14 ✅ Patent 10,898,480 granted on 2021-01-26Pharmaceutical composition for nasal delivery
#15 | 2020-12-24 ✅ Patent 10,946,010 granted on 2021-03-16Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#16 | 2020-08-04 ✅ Patent 10,729,687 granted on 2020-08-04Pharmaceutical composition for nasal delivery
#17 | 2020-05-19 ✅ Patent 10,653,690 granted on 2020-05-19Pharmaceutical composition for nasal delivery
#18 | 2019-02-21 ✅ Patent 10,874,661 granted on 2020-12-29Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#19 | 2017-03-16 ✅ Patent 9,782,396 granted on 2017-10-10Alfentanil composition for the treatment of acute pain
#20 | 2015-10-22 ✅ Patent 9,408,843 granted on 2016-08-09Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#21 | 2015-07-16 ✅ Patent 9,259,421 granted on 2016-02-16Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#22 | 2015-05-14 ✅ Patent 9,345,698 granted on 2016-05-24Alfentanil composition for the treatment of acute pain
#23 | 2014-07-31 ✅ Patent 8,940,330 granted on 2015-01-27Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#24 | 2014-01-30PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE DISORDERS
#25 | 2014-01-23NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE
#26 | 2014-01-02 ✅ Patent 8,815,911 granted on 2014-08-26Alfentanil composition for the treatment of acute pain
#27 | 2013-10-17 ✅ Patent 10,251,834 granted on 2019-04-09Transdermal drug administration device
#28 | 2013-09-05 ✅ Patent 9,597,281 granted on 2017-03-21Pharmaceutical formulations useful in the treatment of insomnia
#29 | 2013-08-01 ✅ Patent 8,821,914 granted on 2014-09-02Non-abusable pharmaceutical composition comprising opioids
#30 | 2013-08-01 ✅ Patent 8,658,198 granted on 2014-02-25Non-abusable pharmaceutical composition comprising opioids
#31 | 2013-08-01PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE DISORDERS
#32 | 2013-03-21NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE
#33 | 2013-01-17GASTRIC ACID SECRETION INHIBITING COMPOSITION
#34 | 2012-12-13 ✅ Patent 8,512,747 granted on 2013-08-20Pharmaceutical composition for the treatment of acute disorders
#35 | 2012-12-13 ✅ Patent 8,454,996 granted on 2013-06-04Pharmaceutical composition for the treatment of acute disorders
#36 | 2012-11-01PHARMACEUTICAL FORMULATIONS USEFUL IN THE TREATMENT OF INSOMNIA
#37 | 2012-05-17 ✅ Patent 9,040,565 granted on 2015-05-261H-benzimidazole-5-carboxamides as anti-inflammatory agents
#38 | 2012-05-17Gastric Acid Secretion Inhibiting Composition
#39 | 2012-01-19 ✅ Patent 9,622,972 granted on 2017-04-18Abuse resistant formula
#40 | 2011-11-03PHARMACEUTICAL FORMULATIONS USEFUL IN THE TREATMENT OF INSOMNIA
#41 | 2011-10-20RAPID-ACTING PHARMACEUTICAL COMPOSITION
#42 | 2010-10-19 ✅ Patent 7,815,940 granted on 2010-10-19Gastric acid secretion inhibiting composition
#43 | 2010-05-27 ✅ Patent 8,470,361 granted on 2013-06-25Non-abusable pharmaceutical composition comprising opioids
#44 | 2008-12-18 ✅ Patent 9,265,720 granted on 2016-02-23Pharmaceutical formulations useful in the treatment of insomnia
#45 | 2008-11-20Pharmaceutical composition for the treatment of acute disorders
#46 | 2007-02-08 ✅ Patent 7,910,132 granted on 2011-03-22Pharmaceutical composition for the treatment of acute disorders
#47 | 2007-02-08 ✅ Patent 7,771,747 granted on 2010-08-10Gastric acid secretion inhibiting composition
#48 | 2006-09-28Rapid-acting pharmaceutical composition
#49 | 2006-06-01 ✅ Patent 7,785,626 granted on 2010-08-31Gastric acid secretion inhibiting composition
#50 | 2005-11-08 ✅ Patent 6,962,687 granted on 2005-11-08Method and means for detecting inflammatory processes
Also check out Orexo AB's (Uppsala, Sweden) applicant profile with 31 patent applications submitted.
4727 ⎘